Abstract
Background It is of great importance to examine the impact of the healthcare reorganization adopted to confront the COVID-19 pandemic on the quality of care provided by healthcare systems to non-COVID-19 patients. The aim of this study is to assess the impact of the COVID-19 national lockdown (March 9, 2020) on the quality of care provided to patients with hip fracture (HF) in Piedmont and Emilia-Romagna, 2 large regions of northern Italy severely hit by the pandemic.
Methods We calculated the percentage of HF patients undergoing surgery within 2 days of hospital admission. An interrupted time-series analysis was performed on weekly data from December 11, 2019 to June 9, 2020 (≈6 months), interrupting the series in the 2nd week of March. The same data observed the year before were included as a control time series with no “intervention” (lockdown) in the middle of the observation period.
Results Before the lockdown, 2-day surgery was 69.9% in Piedmont and 79.2% in Emilia-Romagna; after the lockdown, these proportions were equal to 69.8% (−0.1%) and 69.3% (− 9.9%), respectively. While Piedmont did not experience any drop in the amount of surgery, Emilia-Romagna exhibited a significantly decline at a weekly rate of –1.29% (95% CI = –1.71 to –0.88).
Divergent trend patterns in the 2 study regions reflect local differences in pandemic timing as well as in healthcare services capacity, management, and emergency preparedness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No specific funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval to undertake this research was granted from the Comitato Etico di Area Vasta Emilia Centro (Submission Number IDECOdE-R (233/2019/0SS/AOUBo)). Access to administrative data was conducted in conformity with the Italian Privacy Code (Legislative decree 196/2003, amended by Legislative Decree 101/2018), which exempts from the obligation to seek written informed consent when using pseudonymized data that are primarily collected for healthcare management and healthcare quality evaluation and improvement. According to Articles 99110bis on medical, biomedical, and epidemiological research (Legislative Decree 101/2018), when investigators use data collected by healthcare systems or previous studies, consulting all the participants would represent a disproportionate effort, considering that safeguards such as key-coding (pseudonymization) are in place to protect the data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding statement: The authors received no funding for this work.
Data Availability
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
